Co-Diagnostics IncNASDAQ:CODX
- LAST PRICE1.0600
- TODAY'S CHANGE (%)-0.0400 (-3.6364%)
- Bid / Lots1.0500/ 22
- Ask / Lots1.0600/ 135
- Open / Previous Close1.1000 / 1.1000
- Day Range
- 52 Week Range
- Volume126,029
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CODX |
|---|---|---|
| 09:32 ET | 229 | 1.1 |
| 09:33 ET | 121 | 1.1096 |
| 09:42 ET | 2649 | 1.11 |
| 09:48 ET | 198 | 1.1 |
| 09:51 ET | 178 | 1.1 |
| 10:02 ET | 100 | 1.09 |
| 10:15 ET | 537 | 1.09 |
| 10:18 ET | 300 | 1.0909 |
| 10:22 ET | 500 | 1.098 |
| 10:24 ET | 1185 | 1.09 |
| 10:26 ET | 196 | 1.08 |
| 10:27 ET | 200 | 1.09 |
| 10:29 ET | 5998 | 1.0855 |
| 10:36 ET | 166 | 1.0849 |
| 11:03 ET | 3073 | 1.06 |
| 11:07 ET | 1927 | 1.07 |
| 11:09 ET | 2900 | 1.07 |
| 11:12 ET | 200 | 1.07 |
| 11:18 ET | 1000 | 1.0798 |
| 11:20 ET | 2200 | 1.0793 |
| 11:21 ET | 1400 | 1.0799 |
| 11:25 ET | 786 | 1.0783 |
| 11:27 ET | 1400 | 1.0796 |
| 11:30 ET | 500 | 1.0792 |
| 11:34 ET | 100 | 1.0789 |
| 11:38 ET | 100 | 1.06 |
| 11:48 ET | 2500 | 1.085 |
| 11:59 ET | 2738 | 1.085 |
| 12:01 ET | 6500 | 1.085 |
| 12:06 ET | 200 | 1.081 |
| 12:28 ET | 16206 | 1.07 |
| 12:35 ET | 200 | 1.075 |
| 12:42 ET | 100 | 1.07 |
| 12:57 ET | 100 | 1.07 |
| 01:02 ET | 100 | 1.07 |
| 01:08 ET | 100 | 1.07 |
| 01:11 ET | 1000 | 1.075 |
| 01:22 ET | 1000 | 1.0798 |
| 01:40 ET | 300 | 1.07 |
| 01:47 ET | 1000 | 1.07 |
| 01:49 ET | 100 | 1.07 |
| 01:58 ET | 100 | 1.07 |
| 02:00 ET | 198 | 1.075 |
| 02:09 ET | 9033 | 1.0599 |
| 02:12 ET | 400 | 1.06 |
| 02:20 ET | 524 | 1.0503 |
| 02:21 ET | 187 | 1.0663 |
| 02:27 ET | 2100 | 1.0593 |
| 02:30 ET | 600 | 1.0594 |
| 02:32 ET | 4691 | 1.07 |
| 02:39 ET | 200 | 1.07 |
| 03:17 ET | 740 | 1.07 |
| 03:19 ET | 200 | 1.07 |
| 03:21 ET | 500 | 1.07 |
| 03:26 ET | 498 | 1.0607 |
| 03:28 ET | 200 | 1.07 |
| 03:30 ET | 233 | 1.065 |
| 03:33 ET | 100 | 1.07 |
| 03:37 ET | 550 | 1.0607 |
| 03:39 ET | 1500 | 1.065 |
| 03:42 ET | 1400 | 1.07 |
| 03:44 ET | 1400 | 1.065 |
| 03:48 ET | 3957 | 1.06 |
| 03:50 ET | 9308 | 1.0599 |
| 03:51 ET | 6294 | 1.05 |
| 03:53 ET | 466 | 1.055 |
| 04:00 ET | 1050 | 1.06 |
Nov 11, 2024
DJ Co-Diagnostics Price Target Maintained With a $1.50/Share by HC Wainwright & Co., from 6:55AM ET on Monday Nov 11, 2024 by Dow Jones
6:55AM ET on Monday Nov 11, 2024 by Dow Jones
Nov 7, 2024
Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results, from 4:01PM ET on Thursday Nov 07, 2024 by Dow Jones
4:01PM ET on Thursday Nov 07, 2024 by Dow Jones*DJ Co-Diagnostics 3Q Loss/Shr 32c >CODX, from 4:01PM ET on Thursday Nov 07, 2024 by Dow Jones
4:01PM ET on Thursday Nov 07, 2024 by Dow Jones
Nov 5, 2024
Co-Diagnostics, Inc. to Host Booth at MEDICA Trade Fair in D sseldorf, Germany on Nov 11-14, 2024, from 9:30AM ET on Tuesday Nov 05, 2024 by Dow Jones
9:30AM ET on Tuesday Nov 05, 2024 by Dow Jones
Oct 25, 2024
Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast, from 4:01PM ET on Friday Oct 25, 2024 by Dow Jones
4:01PM ET on Friday Oct 25, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Co-Diagnostics Inc | 33.8M | -0.8x | --- |
Icecure Medical Ltd | 30.1M | -2.1x | --- |
T2 Biosystems Inc | 10.5M | 0.0x | --- |
Renalytix PLC | 32.7M | -0.2x | --- |
Neuroone Medical Technologies Corp | 21.9M | -1.4x | --- |
Medite Cancer Diagnostics Inc | 90.0 | 0.0x | --- |
Company Information
Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
Contact Information
- Headquarters
- 4049 S Highland DrSALT LAKE CITY, UT, United States 84124-1664
- Phone
- 801-278-9769
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Dwight Egan
- President
- Richard Abbott
- Chief Financial Officer, Company Secretary
- Brian Brown
- Chief Operations Officer
- David Nielsen
- Chief Technology Officer
- Christopher Thurston
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $33.8M |
|---|---|
Revenue (TTM) | $7.3M |
Shares Outstanding | 31.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.85 |
EPS | $-1.38 |
Book Value | $2.75 |
P/E Ratio | -0.8x |
Price/Sales (TTM) | 4.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -549.79% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
